Daniella Ballou-Aares - 30 Dec 2025 Form 4 Insider Report for IBEX Ltd (IBEX)

Reporting relationship: Director
Issuer ticker: IBEX
Reported as of: 30 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Dec 2025, 18:55:39 UTC
Prior SEC filing: 17 Apr 2026
Next SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: Lisa Lenstrohm, Attorney-in-Fact

Key filing fact

Daniella Ballou-Aares filed Form 4 for IBEX Ltd (IBEX) on 30 Dec 2025.

Key facts

This page summarizes Daniella Ballou-Aares's Form 4 filing for IBEX Ltd (IBEX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 30 Dec 2025, 18:55.

Change

Previous filing in this sequence was filed on 17 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001973685 Primary reporting owner

Ballou-Aares Daniella

Relationship: Director
Address: C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON
Signature: Lisa Lenstrohm, Attorney-in-Fact
Signature date: 30 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IBEX transaction

Common Shares

Options Exercise

Transaction value: $39,254
Shares: +2,066
Change %: +16%
Price: $19.00
Shares after: 15,060
Date: 30 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IBEX transaction Derivative

Stock Option (Right to Buy Common Shares)

Options Exercise

Transaction value: $39,254
Shares: -2,066
Change %: -100%
Price: $19.00
Shares after: 0
Date: 30 Dec 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 2,066
Exercise price: $19.00
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Transaction to exercise options was submitted by Reporting Person on November 22, 2025, with payment received and shares released by the Issuer on December 30, 2025.

Footnote F2

The shares subject to this option are fully vested and exercisable.